Lord, Abbett & Co. LLC Mirum Pharmaceuticals, Inc. Transaction History
Lord, Abbett & Co. LLC
- $31.1 Billion
- Q2 2025
A detailed history of Lord, Abbett & Co. LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 771,146 shares of MIRM stock, worth $49.9 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
771,146
Previous 813,398
5.19%
Holding current value
$49.9 Million
Previous $36.6 Million
7.1%
% of portfolio
0.13%
Previous 0.13%
Shares
4 transactions
Others Institutions Holding MIRM
# of Institutions
230Shares Held
56.1MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$440 Million18.24% of portfolio
-
Janus Henderson Group PLC London, X05.24MShares$339 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$210 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$179 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$171 Million2.55% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.38B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...